1. Home
  2. ATAI vs AFCG Comparison

ATAI vs AFCG Comparison

Compare ATAI & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • AFCG
  • Stock Information
  • Founded
  • ATAI 2018
  • AFCG 2020
  • Country
  • ATAI Germany
  • AFCG United States
  • Employees
  • ATAI N/A
  • AFCG N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • AFCG Real Estate Investment Trusts
  • Sector
  • ATAI Health Care
  • AFCG Real Estate
  • Exchange
  • ATAI Nasdaq
  • AFCG Nasdaq
  • Market Cap
  • ATAI 222.3M
  • AFCG 196.7M
  • IPO Year
  • ATAI 2021
  • AFCG 2021
  • Fundamental
  • Price
  • ATAI $1.50
  • AFCG $8.39
  • Analyst Decision
  • ATAI Strong Buy
  • AFCG Buy
  • Analyst Count
  • ATAI 4
  • AFCG 6
  • Target Price
  • ATAI $9.00
  • AFCG $12.00
  • AVG Volume (30 Days)
  • ATAI 1.9M
  • AFCG 219.0K
  • Earning Date
  • ATAI 11-13-2024
  • AFCG 03-06-2025
  • Dividend Yield
  • ATAI N/A
  • AFCG 15.72%
  • EPS Growth
  • ATAI N/A
  • AFCG N/A
  • EPS
  • ATAI N/A
  • AFCG 0.40
  • Revenue
  • ATAI $331,000.00
  • AFCG $43,164,939.00
  • Revenue This Year
  • ATAI $80.07
  • AFCG N/A
  • Revenue Next Year
  • ATAI N/A
  • AFCG N/A
  • P/E Ratio
  • ATAI N/A
  • AFCG $21.03
  • Revenue Growth
  • ATAI N/A
  • AFCG N/A
  • 52 Week Low
  • ATAI $1.03
  • AFCG $7.45
  • 52 Week High
  • ATAI $2.85
  • AFCG $10.88
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 52.34
  • AFCG 40.87
  • Support Level
  • ATAI $1.36
  • AFCG $8.22
  • Resistance Level
  • ATAI $1.50
  • AFCG $8.49
  • Average True Range (ATR)
  • ATAI 0.15
  • AFCG 0.25
  • MACD
  • ATAI -0.00
  • AFCG 0.04
  • Stochastic Oscillator
  • ATAI 41.43
  • AFCG 45.59

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

About AFCG AFC Gamma Inc.

Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to state-law-compliant cannabis operators in the U.S. Through the management team's deep network and significant credit and cannabis expertise, AFC originates, structures and underwrites loans ranging from $10 million to over $100 million, typically secured by quality real estate assets, license value and cash flows.

Share on Social Networks: